The Orthopaedic Implant Company Celebrates Ten Years

The Orthopaedic Implant Company (OIC) is celebrating its 10-year anniversary, marking a decade of challenging convention in the orthopaedic industry to lower costs without compromising implant quality and patient outcomes. OIC has created a truly unique, value-based business model that benefits patients, physicians and hospital systems.

Back in 2010, Itai Nemovicher, OIC’s current president and CEO, recognized the vast challenges associated with rising implant costs. Working then as a sales manager for a big box orthopaedic company, Nemovicher witnessed first-hand how the lack of clear pricing standards driven by profit-first corporate mentality was negatively impacting the lives of those undergoing orthopaedic surgeries and excessively burdening the healthcare system. Something had to change.

Nemovicher soon partnered with orthopaedic trauma surgeon Peter Althausen, and together they conceived a way to change the orthopaedic implant business by eliminating excessive and extraneous sales and marketing expenses, focusing on a simplified delivery model. With a well-versed knowledge of the industry and a dedication to providing better clinical and financial outcomes, OIC was established in September 2010 in Reno, Nevada.

“We are proud to recognize this milestone and reflect on the progress we have achieved as a company while also identifying that this is just the beginning,” said Nemovicher. “Throughout the last decade, we’ve focused our efforts on redefining what orthopaedic pricing and delivery should really look like. From revealing the underlying mechanisms that significantly raise the costs associated with products distributed by conventional vendors to demonstrating the importance of price transparency, our goal is, and always will be, creating a better system with greater benefits for patients, physicians and hospitals.”

OIC recently launched the “One Procedure, One Price” initiative dedicated to reducing the expense of orthopaedic procedures and creating a new standard cost of care. Surgeons, ASCs, community hospitals, academic hospitals and Level 1 trauma centers in all corners of the country call OIC a trusted partner, and clinical studies^1,2 have been published proving OIC’s clinical equivalency to premium-branded devices while delivering unheralded value.

References
¹ J Orthop Trauma | Volume 30, No 12 Supplement, Dec 2016.
² The American Journal of Orthopaedics, Sep 2014.